ANALYSIS OF IMMUNITY IN OSTEOSARCOMA AS A BASIS FOR DEVELOPMENT FOLLOWING THERAPY
Downloads
Background: Osteosarcoma is a malignant bone disease. Predictors which used to determine osteosarcoma from non-invasive (stage IIB) to invasive (stage III), through the ratio of macrophages-1 (M-1) which are pro-inflammatory (anti-cancer) with macrophages-2 (M-2) which have anti-inflammatory characteristic (pro cancer) is not clear yet.
Purpose: To elaborate the role of M-1 ratio with M-2 in the development of non-invasive osteosarcoma become invasive, in effort to obtain predictors that can be used to the selection of neoadjuvant therapy time.
Methods: An observational study with cross sectional analytic study design. The sample of this research were all of paraffin blocks containing osteosarcoma patient tissue, collected within 5 years. The number of samples that met the inclusion criteria was 26 samples, and then divided into two groups, namely group-I as many as 13 stages IIB and group-II as many as 13 samples of stage III. The measured variables are the number of macrophages that express TNF-α and those that express IL-10 by immunohistochemical methods.
Results: Analysis of the data using a Mann-Whitney test, and the results were obtain is the number of macrophages expressing TNF-α in group-I was greater than in group-II (p <0.05). Likewise, macrophages that expressed IL-10 in group I were smaller than in group-II (p <0.05).
Conclusion: The M-1 ratio which reflected by TNF-α expression cells with M-2 as reflected by IL-10 expression cells in the non-invasive group is 5: 1.Whereas in the group that develops to invasive is 1:6.Xu M., S. F.Xu., X. C. Yu. Clinical analisis of osteosarcoma patients treated with high-dosteosarkomae methotrexate-free neoadjuvant chemoterphy. J. Curr Oncol. 2014; 21(5): e678-e684.
Chuang Y., Brianne KK., Josteosarkomahua NL. Regulation the IL-10-driven macrophage phenotype under incoherent stimuli, Publish Online Sep, 26. J. Inate Immunol. 2016;22(8): 647-657.
Sudiana IK. Imunopatobiologi Molekuler cetakan pertama. Airlangga University Press. 2014; hal.12-14.
Gerald UF, Adrienne MG, Afshin S. Heat Shock and Regulation of Apoptosteosarkomais in Neural Cells, edited by Christine Richter-Landsberg. 2005; p.1-5.
Sudiana IK. Patobiologi Molekuler Kanker. Jakarta: Salemba Medika. 2008; hal. 50-53.
Kurahara H., Hiroyuki S., Yuko M., Kousei M., Hidetosteosarkomahi N., Fumitake K., Masahiko S., Shinichi U., Shoji N., Sonshin T. Significance of M-2 polarized Tumor-Associated Macrophage in Pancreatic cancer. J. Surgical Research, Published Online 2009.
Wang R., Meng Lu, Jie Zhang, Sufeng C., Xiaoyang L., Ying Q., Haiquan C. Increased IL-10 expression in tumor-associated macropgage correlated with late stage of lung cancer. Published Online. May 20, J.Exp Clin Cancer Res. 2011;30(1): 62.
Yang J, Zhang L, Yu C. Monocyte and Macrophage Differentiation: Circulation Inflammatory monocyte as Biomarker for inflammatory Diseases. ListBiomark resv. 2014; vol 2, no.1.
Weagel E, Curren S, Ping GL, Richard R, kim ON. Macrophage Polarization and Its Role in Cancer. J. Clin & Cell Immun. 2015;6: 338
Sudiana IK. Hantaran Sinyal pada prosteosarkomaes Inflamasi cetakan pertama. Airlangga University Press;2017; hal.32-35, 62-63.
Chow AY. Cell cycle Control by oncogenes and tumor suppressor : Driving the transformation of normal Cells into Cancerous cell. J. Nature Education. 2010; 3(9): 7.
Weinberg. Oncogenes and Tumor Suppressor Genes. J. Clin Cancer. 1994; (44):160-170.
Feghali CA., Timothy M. Cytokines in Acute and Chronic Inflammation. J. Biosteosarkomacience.1997;vol.2 p.2-16.
Bianchi ME. DAMPs, PAMPs and alarmins : all we need to know about danger. J.Leuco Biol Banner. 2006; 81(1): 1-5.
Kuby. Immunology,4th edition, New York, WH Freeman and Company. 2000; p.386.
Italiani P, Diana B. From Monocyte to M-1/M-2 Macrophages: phenotypical vs Fuctional Differentiation. J. Fron Immunol. 2014;5: 514.
Jorine JLP Voss, Catriona AF, Sofia P, Lynsey M, Margaret P, John DP, Pam H, Bruno G, Tom CF, Christopher DG. Modulation of Macrophage antitumor potential by apoptotic lymphoma cells. J. Cell Death and Differentiation. 2017; 24,971-983.
Zamai L., Cristina P., Prisco M., Giuliana G., Stefano P., Laura G., Lucio C. Marco V. NK cell and Cancer. J. Immunol. 2017; 178: 4011-4016.
Weigert A, Nico T, Andreas VK, Axel MJ, Helmut S, Gerd G, Bernhard B. Tumor cell Apoptosis Polarized Macrophages-Role of Sphingosine -1 phosphate. J. Mol Bio Cell. 2007; 18(10): 3810-3819.
Li Yang, Yi Zhang. Tumor-associated macrophages: from basic research to clinical application. J. Hematol and oncol. 2017; 10:55.
Kratochvill F, Geoffrey N, Jessica MH, Lee AV, Amber MS, Daisuke K. TNF counterbalances the emergence of M-2 tumor macrophages. HHS publish. 2015;12(11): 1902-1914.
Martinez FO, Siamon G. 2014; F1000 Prine Publish online Mar 3, doi 10: 12703/p6-13.
Cooper GM. The Cell : A Molecular Approach.2nd edition, Sunderland, Bosteosarkomaton University, 2000.
Yuan Shih J., Ang Yuan, Jeremy JW., Chen, Pan-Chyr Yang. Tumor Associated Macrophage: It's Role in Cancer Invasion and Metastasis. J. Cancer Molecules. 2006;2(3): 101-106.
Shanker S I, Genhong C. Role of Interleukin 10 Transcriptional Regulation in inflammation and Auto imun Diseases. J. Immunol. 2012; 32(1): 23-63.
Eddie WK, NamikoH, Dror SS, Scott S, Ruslan M. Anti inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017; 356(6337):13-519.
Sica A. Tiziana S., Alberto M., Paulo A. Tumour associated macrophagea are distinct M-2 Polarised population promoting tumour progression: Potensial targets of anti cancer therapy. European. J.Cancer. 2006;42: 717-727.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (